DrugSupplement
Saccharomyces cerevisiae clinical trials
Also written Saccharomyces boulardii.
Keep track of what changes. Save the Saccharomyces cerevisiae studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
32 studies that test it; most in 2010 (4)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 28
Biocodex (3) · Lesaffre International (2) · Beth Israel Deaconess Medical Center (2) · Federal University of Minas Gerais (2) · Aga Khan University (2) · Syeda Sabeen Fatima Naqvi (1) · Seoul National University Hospital (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1)
Often tested with
Tested in the same studies.
Bacillus clausii (2) · Amoxicillin (2) · Proton Pump Inhibitors (1) · Metronidazole (1) · Probiotic (1) · VPS Coriolus versicolor extract (1) · Clavulanic Acid (1) · Rifaximin (1)
Studies
Open first, then newest update. How each study uses Saccharomyces cerevisiae is read from its arms, and is right about nine times in ten.
Testing it · 33
- Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated DiarrheaNot yet recruitingNot applicableUniversity of Child Health Sciences and Children's Hospital, LahoreNCT07785206Written as Saccharomyces boulardii
- Saccharomyces Boulardii CNCM I-745 in Irritable Bowel SyndromeRecruitingPhase 3BiocodexNCT07168434Written as Saccharomyces Boulardii 250 MG
- Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori InfectionNot yet recruitingNot applicableZhongda HospitalNCT07012785Written as Saccharomyces boulardii
- Comparison of Bacillus Clausii and Saccharomyces Boulardii for Acute Diarrhea at Day 3Active, not recruitingNot applicableSyeda Sabeen Fatima NaqviNCT07853846Written as Saccharomyces boulardii
- Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor UsersCompletedPhase 4Seoul National University HospitalNCT07852676Written as Saccharomyces Boulardii 250 MG
- A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract InfectionsCompletedEarly Phase 1Ann & Robert H Lurie Children's Hospital of ChicagoNCT06149676Written as Saccharomyces Boulardii 250 MG [Florastor]
- Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric PatientsCompletedNot applicableRESnTEC, Institute of ResearchNCT06540209Written as Saccharomyces boulardii
- Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.CompletedNot applicableInstituto Mexicano del Seguro SocialNCT05226052Written as Saccharomyces boulardii (Floratil 600mg)
- Saccharomyces Cerevisiae for Irritable Bowel SyndromeCompletedPhase 1/2Ziauddin UniversityNCT05149599Written as Saccharomyces cerevisiae
- The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBSStatus unknownNot applicableFakultas Kedokteran Universitas IndonesiaNCT05451433Written as Saccharomyces Boulardii 250 MG
- Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter PyloriCompletedNot applicableThe Third Xiangya Hospital of Central South UniversityNCT05191875Written as Saccharomyces Boulardii 250 MG
- Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter PyloriCompletedNot applicableHuazhong University of Science and TechnologyNCT03688828Written as Saccharomyces boulardii
- Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial OvergrowthCompletedPhase 4Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoNCT04627337Written as Saccharomyces Boulardii 250 MG
- Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic SclerosisCompletedPhase 4Coordinación de Investigación en Salud, MexicoNCT03692299Written as Saccharomyces Boulardii Oral Tablet
- Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces BoulardiiStatus unknownPhase 4Clinical Centre of SerbiaNCT03997279Written as Saccharomyces boulardii
- GutHeart: Targeting Gut Microbiota to Treat Heart FailureStatus unknownPhase 2Oslo University HospitalNCT02637167Written as Saccharomyces boulardii
- Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in ChildrenCompletedPhase 4BiocodexNCT03539913Written as Probiotic : Saccharomyces boulardii
- Efficacy of Two Probiotic Preparations in Children With Acute DiarrhoeaWithdrawnNot applicableSinaloa Pediatric HospitalNCT02080130Written as Saccharomyces boulardii
- Effect of Saccharomyces Cerevisiae in LDL CholesterolCompletedNot applicableLesaffre InternationalNCT02990260Written as Saccharomyces cerevisiae
- Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic PeriodontitisCompletedPhase 1/2Tatyasaheb Kore Dental CollegeNCT03516370Written as Saccharomyces Boulardii 250 MG
See all 33 studies that test Saccharomyces cerevisiae →
Given in every arm · 1 — Saccharomyces cerevisiae is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Saccharomyces cerevisiae
- A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineCompletedPhase 2Beijing Health Guard Biotechnology, IncNCT05694728Written as Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
- A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV VaccineStatus unknownPhase 3Beijing Health Guard Biotechnology, IncNCT05668572Written as Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
Codes
What other systems call Saccharomyces cerevisiae · ClinicalTrials.gg INT015814
- UNII (FDA) 978D8U419HSACCHAROMYCES CEREVISIAEConfirmed FDA, Wikidata
- RxNorm 9511Confirmed FDA, Wikidata
- Wikidata Q719725Saccharomyces cerevisiaeConfirmed FDA, Wikidata
- NCI Thesaurus C14271Saccharomyces cerevisiaeOne source FDA
- DrugBank DB10447One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 978D8U419H | SACCHAROMYCES CEREVISIAE | Confirmed FDA, Wikidata |
| RxNorm | 9511 | — | Confirmed FDA, Wikidata |
| Wikidata | Q719725 | Saccharomyces cerevisiae | Confirmed FDA, Wikidata |
| NCI Thesaurus | C14271 | Saccharomyces cerevisiae | One source FDA |
| DrugBank | DB10447 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.